Norway Analgesics Market Size & Outlook, 2022-2030
The analgesics market in Norway is expected to reach a projected revenue of US$ 180.1 million by 2030. A compound annual growth rate of 5.8% is expected of Norway analgesics market from 2023 to 2030.
Revenue, 2022 (US$M)
$114.3
Forecast, 2030 (US$M)
$180.1
CAGR, 2023 - 2030
5.8%
Report Coverage
Norway
Norway analgesics market, 2018-2030 (US$M)
Related Markets
Norway analgesics market highlights
- The Norway analgesics market generated a revenue of USD 114.3 million in 2022 and is expected to reach USD 180.1 million by 2030.
- The Norway market is expected to grow at a CAGR of 5.8% from 2023 to 2030.
- In terms of segment, non-opioid was the largest revenue generating drug type in 2022.
- Compound Medication is the most lucrative drug type segment registering the fastest growth during the forecast period.
Analgesics market data book summary
| Market revenue in 2022 | USD 114.3 million |
| Market revenue in 2030 | USD 180.1 million |
| Growth rate | 5.8% (CAGR from 2022 to 2030) |
| Largest segment | Non-opioid |
| Fastest growing segment | Compound Medication |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Opioid, Non-opioid, Compound Medication |
| Key market players worldwide | Bayer AG, Assertio Holdings Inc, Johnson & Johnson, GSK PLC, AbbVie Inc, Novartis AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, Norway accounted for 0.3% of the global analgesics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany analgesics market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 2,032.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Analgesics Market Scope
Analgesics market segmentation & scope
Analgesics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway analgesics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to analgesics market will help companies and investors design strategic landscapes.
Non-opioid was the largest segment with a revenue share of 51.71% in 2022. Horizon Databook has segmented the Norway analgesics market based on opioid, non-opioid, compound medication covering the revenue growth of each sub-segment from 2018 to 2030.
- Norway Analgesics Drug Type Outlook (Revenue, USD Million, 2018-2030)
- Opioid
- Non-opioid
- Compound Medication
- Norway Analgesics Application Outlook (Revenue, USD Million, 2018-2030)
- Musculoskeletal
- Surgical and Trauma
- Cancer
- Neuropathic
- Migraine
- Obstetrical
- Fibromyalgia
- Pain due to Burns
- Dental/Facial
- Pediatric
- Other Drug Type
- Norway Analgesics Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Parenteral
- Transdermal
- Other Route of Administrations
- Norway Analgesics Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Reasons to subscribe to Norway analgesics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway analgesics market databook
-
Our clientele includes a mix of analgesics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway analgesics market, including forecasts for subscribers. This country databook contains high-level insights into Norway analgesics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway analgesics market report size, by drug type, 2018-2030 (US$M)
Norway Analgesics Market Share, 2022 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
